ADVANCED OVARIAN CANCER
Clinical trials for ADVANCED OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OVARIAN CANCER trials appear
Sign up with your email to follow new studies for ADVANCED OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ovarian cancer surgery showdown: tumor removal vs. bowel resection
Disease control Recruiting nowThis study looks at two different surgeries for advanced ovarian cancer that has spread to the bowel. One method removes only the tumor from the bowel, while the other removes a piece of the bowel along with the tumor. The goal is to see which approach helps patients live longer …
Matched conditions: ADVANCED OVARIAN CANCER
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug DSB2455 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called DSB2455 in adults with advanced cancers (breast, ovarian, prostate, pancreatic, or brain metastases) that have a specific DNA repair problem. The main goals are to check safety and see if the drug shrinks tumors. About 180 participan…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE1 • Sponsor: Duke Street Bio Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo shows promise for tough gynecological cancers
Disease control Recruiting nowThis study tests an experimental drug called SKB518, given alone or with chemotherapy, in 280 people with advanced ovarian, cervical, or endometrial cancers. The goal is to see if the drug can shrink tumors or slow cancer growth. Researchers will also monitor side effects.
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New experimental drug BMS-986500 enters first human trials for advanced cancers
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called BMS-986500 in people with advanced solid tumors or breast cancer that has not responded to prior treatments. The study will first test the drug alone, then in combination with other cancer drugs (palbociclib and fulves…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New antibody drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called MOv18 IgE in people with advanced ovarian, endometrial, or triple-negative breast cancers that have a specific protein (folate receptor alpha) on their cells. The study has two parts: first, finding the safest dose, an…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: PHASE1 • Sponsor: Epsilogen Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Immune cell combo shows promise against tough gynecologic cancers
Disease control Recruiting nowThis early-phase study tests a new treatment that combines specially grown immune cells (cCTL) with immunotherapy for people with advanced gynecologic cancers like ovarian, cervical, or endometrial cancer. The goal is to see if the combination is safe and can shrink tumors. About…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: EARLY_PHASE1 • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Exercise before ovarian cancer surgery may reduce frailty and boost recovery
Symptom relief Recruiting nowThis study tests whether a 4-week exercise program before surgery can reduce frailty and improve recovery in women with advanced ovarian cancer. Frailty affects about half of these patients and often leads to worse surgical outcomes and chemotherapy delays. The program includes l…
Matched conditions: ADVANCED OVARIAN CANCER
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC